Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways.

Source:http://linkedlifedata.com/resource/pubmed/id/20511288

Download in:

View as

General Info

PMID
20511288